RESUMEN
The environment of an asthmatic patient can contain numerous sources of pollutants that degrade the quality of indoor air and have major repercussions on the occurrence and control of asthma. Assessment and improvement of the quality of indoor air should be assigned a major role in pneumology and allergology consultations. Characterization of an asthmatic's environment entails a search for biological pollutants with mite allergens, mildew, and allergens resulting from the proximity of pets. It is important to evaluate the chemical pollution represented by exposure to volatile organic compounds, which are increasingly present in our lodgings. Active or second-hand smoking must in all circumstances be sought out and quantified. Assessment of the environment is mediated by several methods, of which the application depends not only on the pollutant sought out, but also on enzyme-linked immunosorbent assay (ELISA), which has an essential role in quantification of biological pollutants. Attempts at expulsion of the different indoor environment pollutants is mediated by indoor environment advisors, whose efforts are aimed at obtaining reliable evaluation and control of indoor air. Implemented as a form of tertiary prevention, their methods are conducive to improved asthma control, in adults as well as children.
Asunto(s)
Contaminantes Atmosféricos , Contaminación del Aire Interior , Asma , Contaminantes Ambientales , Niño , Adulto , Humanos , Alérgenos/análisis , Contaminación del Aire Interior/efectos adversos , Contaminación del Aire Interior/análisis , Contaminantes Ambientales/análisis , Asma/epidemiología , Asma/etiología , Asma/prevención & control , Contaminantes Atmosféricos/efectos adversos , Contaminantes Atmosféricos/análisisRESUMEN
BACKGROUND: Scant data are currently available about a potential link between comorbid chronic lung diseases (CLD) and the risk and severity of the coronavirus disease 2019 (COVID-19) infection. METHODS: To describe the clinical characteristics of and outcomes for patients with COVID-19 infection, including patients with comorbid respiratory diseases, who have been primarily hospitalized in the pulmonology department of Strasbourg University Hospital, France. In this retrospective, single-center study, we included all confirmed cases of COVID-19 from March 3 to April 15, 2020. We then compared the symptoms, biological and radiological findings, and outcomes for patients with and without CLD. RESULTS: Of the 124 patients that were enrolled, the median age was 62 years, and 75 patients (60%) were male. Overall, 40% of patients (n=50) had preexisting CLD, including chronic obstructive pulmonary disease (COPD) (n=15, 12%) and asthma (n=19, 15%). Twenty-eight patients were transferred to the intensive care unit (ICU), and six patients died in our unit. CLD were not predictive of ICU hospitalization, but a significantly higher total mortality was observed (17.6% vs. 5.5%, P<0.05) in these patients. CONCLUSIONS: Our results suggest the lack of an over-representation of CLD in COVID-19, representing 40% of patients in this cohort and even within a pulmonology department. CLD were not a risk factor for ICU management. However, a tendency to higher global mortality was observed in COVID-19 patients with CLD. Further studies are warranted to determine the risk of COVID-19 for patients with comorbid CLD.
Asunto(s)
COVID-19/terapia , Enfermedad Crónica/terapia , Enfermedades Pulmonares/terapia , Anciano , Antibacterianos/uso terapéutico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Anticoagulantes/uso terapéutico , Antivirales/uso terapéutico , COVID-19/epidemiología , Enfermedad Crónica/epidemiología , Comorbilidad , Presión de las Vías Aéreas Positiva Contínua , Diabetes Mellitus/epidemiología , Femenino , Francia/epidemiología , Insuficiencia Cardíaca/epidemiología , Mortalidad Hospitalaria , Hospitalización , Hospitales Universitarios , Humanos , Hidroxicloroquina/uso terapéutico , Hipertensión/epidemiología , Unidades de Cuidados Intensivos , Enfermedades Pulmonares/epidemiología , Masculino , Persona de Mediana Edad , Ventilación no Invasiva , Obesidad/epidemiología , Terapia por Inhalación de Oxígeno , Estudios Retrospectivos , Síndromes de la Apnea del Sueño/epidemiología , Fumar/epidemiologíaRESUMEN
Allergy is a hypersensitivity reaction induced by immunological mechanisms. In asthma, allergy has a complex role and is usually IgE mediated. Allergy must be evaluated during the work up but evidence of IgE sensitivity does not mean that allergens play a role in the pathophysiology of the disease. The clinical relevance of the sensitivity has to be considered. This paper describes current available tools to screen for IgE sensitivity, allergen exposure and their role in asthma.
Asunto(s)
Asma/complicaciones , Asma/diagnóstico , Hipersensibilidad/complicaciones , Alérgenos/inmunología , Asma/inmunología , Pruebas de Provocación Bronquial , Humanos , Hipersensibilidad/diagnóstico , Inmunoglobulina E/sangre , Pruebas CutáneasRESUMEN
Very little is known about insulin signalling in schistosomes despite its potential importance in host-parasite molecular dialogue and parasite growth and development. The recent characterization of two insulin receptors (SmIR-1 and SmIR-2) in Schistosoma mansoni has led us to reconsider the question of the potential importance of insulin in host-schistosome interactions. In this work, we demonstrated that insulin could regulate glucose uptake in schistosomes and we investigated the implication of SmIR-1 and SmIR-2 in this process. The possibility that specific inhibitors of SmIR-1 and SmIR-2 tyrosine kinase activities could be developed to target schistosomes is discussed.
Asunto(s)
Adenosina Trifosfato/metabolismo , Glucosa/metabolismo , Receptor de Insulina/metabolismo , Schistosoma mansoni/metabolismo , Esquistosomiasis mansoni/parasitología , Secuencia de Aminoácidos , Animales , Biomphalaria/parasitología , Cricetinae , Interacciones Huésped-Parásitos/fisiología , Humanos , Insulina/sangre , Insulina/metabolismo , Mesocricetus , Proteínas Tirosina Quinasas/metabolismo , Interferencia de ARN , Receptor de Insulina/química , Receptor de Insulina/clasificación , Esquistosomiasis mansoni/metabolismo , Alineación de SecuenciaRESUMEN
Rhinitis and asthma are common diseases that are strongly linked from both the epidemiological and patho-physiological point of view. A precise aetiological diagnosis is required in order to optimize treatment. Nasal provocation tests (NPT) determine precisely the role of the allergen in the initiation of the symptoms of rhinitis particularly when the history does not produce convincing evidence of the clinical relevance of an allergen. It may also have important consequences for the choice of an allergenic immunotherapy. NPT are not standardized but simple methods based on international recommendations provide us with good diagnostic accuracy. In this paper, we will discuss the practical aspects of NPT as well as the clinical or research situations where they may be useful for the respiratory physician.
Asunto(s)
Asma/diagnóstico , Pruebas de Provocación Nasal , Neumología , Rinitis/diagnóstico , Alérgenos/administración & dosificación , Humanos , Pruebas de Provocación Nasal/métodos , Pruebas de Provocación Nasal/normas , Pautas de la Práctica en Medicina/estadística & datos numéricos , Valor Predictivo de las Pruebas , Neumología/métodos , Neumología/normas , Rinitis Alérgica Perenne/diagnóstico , Rinitis Alérgica Estacional/diagnóstico , Pruebas CutáneasRESUMEN
Airborne allergic diseases (allergic asthma, rhinitis and conjunctivitis) have reached epidemic proportions and are a great burden for both society and individuals. Therefore we need to better understand the physiopathological mechanisms and to increase clinical research in these diseases. However, traditional outpatient studies are difficult and have number of limitations, in particular the variability of allergen exposure. Yet allergen provocation tests, especially bronchial challenges in asthma, are excellent tools to measure the efficiency of anti-allergic therapies. Environmental exposure chambers (EEC) allow the performance of controlled allergen provocation tests on a large scale with remarkable sensitivity, specificity and reproducibility. Moreover, they allow a precise collection of allergic symptoms, making them interesting tools for patho-physiological and clinical studies. During the last thirty years, they have assisted the study of anti-allergic therapies and provided data on their pharmacodynamic characteristics, particularly in allergic rhinitis. However, there are still no EEC tests centered on asthma. The EEC of Strasbourg (ALYATEC®) was developed to fulfill two objectives: to allow standardized allergenic and non-allergenic exposures with better control of the parameters than in other EEC and to offer a place to study asthma and anti-asthmatic therapies safely.
Asunto(s)
Cámaras de Exposición Atmosférica , Investigación Biomédica/instrumentación , Pruebas de Provocación Bronquial/instrumentación , Ambiente Controlado , Investigación Farmacéutica/instrumentación , Asma/diagnóstico , Investigación Biomédica/métodos , Pruebas de Provocación Bronquial/métodos , Exposición a Riesgos Ambientales , Humanos , Investigación Farmacéutica/métodos , Reproducibilidad de los Resultados , Rinitis Alérgica/diagnósticoRESUMEN
INTRODUCTION: In COPD, the risk attributable to smoking is very variable according to published studies. A significant number shows that the risk of COPD in non-smokers is far from negligible. The links between COPD and pollution of the interior environment vary between developed and developing countries. STATE OF THE ART: In developing countries, numerous studies have shown a link between COPD and exposure to substances derived from the combustion of biomass fuels, particularly in women where the exposure is the greatest. Nevertheless, a cause and effect relationship has not always been demonstrated. In developed countries, there is no evidence of a role of exposure to domestic interior pollution in the genesis of COPD and interior pollutants such as NO2 and particulates seem only to aggravate already existing COPD. CONCLUSION: Further studies are necessary to evaluate their role in COPD and explore the underlying mechanisms. Irritative phenomena could be involved.